Fracture News and Research

RSS

JAMA study: Higher spending = better quality in Canadian hospitals

Canadian hospitals that spent the most on patient care may be getting a bigger bang for their buck than their U.S. counterparts, researchers suggested. A study reported in the Journal of the American Medical Association compared patient results between Canadian hospitals that spent more on care, and those that spent less.

15 Mar 2012

EffRx receives FDA approval for BINOSTO to treat osteoporosis

EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.

15 Mar 2012

Highlights from Journal of the American Academy of Orthopaedic Surgeons

The Spine Patient Outcomes Research Trial (SPORT) is the first comprehensive study to look at the effectiveness of different treatments for low back and leg pain. It was designed to provide data and outcomes to guide doctors and their patients in their treatment choices for three common spinal disorders: intervertebral disk herniation (IDH), degenerative spondylolisthesis (DS), and lumbar spinal stenosis (LSS).

14 Mar 2012

Higher spending on effective procedures and services leads to better patient outcomes

Among hospitals in Ontario, Canada, those with higher levels of spending, which included higher intensity nursing and greater use of specialists and procedures, had an associated lower rate of deaths, hospital readmissions, and better quality of care for severely ill hospitalized patients, according to a study in the March 14 issue of JAMA.

14 Mar 2012

Biomedical research advances through new Australian Institute

The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.

14 Mar 2012

FDA approves Covidien's EverFlex Self-Expanding Peripheral Stent System

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.

7 Mar 2012

$Vitamin D may reduce risk of stress fracture in girls$

Vitamin D may reduce risk of stress fracture in girls

Vitamin D may be associated with a lower risk of developing stress fractures in preadolescent and adolescent girls, especially among those very active in high-impact activities, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

6 Mar 2012

$Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study$

Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study

A new study shows that girls and young women who got lots of vitamin D through their diet and supplements were half as likely to suffer a stress fracture as those who didn't.

5 Mar 2012

$DXA scan should be done at shorter intervals for women at high risk for fracture$

DXA scan should be done at shorter intervals for women at high risk for fracture

Although a recent study suggests that women with normal results on dual-energy X-ray absorptiometry (DXA) scans at ages 67 and older may wait up to 15 years for a second test, a Viewpoint article published today in the Journal of Bone and Mineral Research (JBMR) cautions that such a lengthy interval is inappropriate for many adults.

2 Mar 2012

Maturitas publishes EMAS' clinical guide on SERMs against postmenopausal osteoporosis

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of an important clinical guide from the European Menopause and Andropause Society (EMAS) in the February issue of Maturitas.

29 Feb 2012

Telephone-based counseling program does not improve osteoporosis medication adherence

Telephone motivational counseling sessions did not result in a statistically significant improvement in adherence to an osteoporosis medication regimen, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.

28 Feb 2012

Aesculap, Osseon partner to distribute VCF treatment devices

Osseon Therapeutics, Inc. announced today that the company has entered into an International Distribution Agreement with Aesculap AG to distribute its vertebral compression fracture (VCF) treatment devices, including its new CE-Mark approved device – Osseoflex SB (steerable balloon) in select regions of Europe and Asia.

From B. Braun Melsungen AG 27 Feb 2012

Mechanical dose of load through muscle force may slow bone loss in SCI patients

Loss of bone density leads to brittle bones that fracture easily. It is a major complication of spinal cord injury (SCI), which affects about 250,000 Americans every year.

17 Feb 2012

Smart sensors can enable orthopaedicians to collect objective, quantifiable information

Imagine a smart sensor customized to provide vital, real-time information about a patient's recent orthopaedic surgery. Instead of relying on X-rays or invasive procedures, surgeons will be able to collect diagnostic data from an implantable sensor.

15 Feb 2012

Cartilage graft can stimulate bone regeneration

A person has a tumor removed from her femur. A soldier is struck by an improvised explosive device and loses a portion of his tibia. A child undergoes chemotherapy for osteosarcoma but part of the bone dies as a result.

14 Feb 2012

$Hip fracture patients should be screened for cervical myelopathy$

Hip fracture patients should be screened for cervical myelopathy

Hip fractures are a common cause of morbidity and mortality in elderly patients. Cervical myelopathy is a common neurological condition that can diminish balance and coordination. In new research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), investigators screened 28 hip fracture patients and 35 hip replacement patients for cervical myelopathy. Eighteen percent (five) of the hip fracture patients did indeed have cervical myelopathy. None of the hip replacement patients tested positive for the condition.

10 Feb 2012

$Bisphosphonates may raise risk of atypical femur fracture$

Bisphosphonates may raise risk of atypical femur fracture

There is growing evidence that supports an association between atypical fractures of the femur- a rare break of the thigh bone, typically without trauma - and the use of bisphosphonates, drugs proven to enhance bone density and reduce fracture incidence caused by osteoporosis.

9 Feb 2012

Injuries in overweight and obese children more often from 'low-energy' impact

Obese children are 74 percent more likely to sustain a fracture of the growth plate, the softer end of the bone where growth occurs. A new study presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), involved 224 children visiting a Maryland hospital with a fracture.

9 Feb 2012

BioMimetic to launch new bone graft substitute product line at AAOS meeting

BioMimetic Therapeutics, Inc. today announced it will introduce Augmatrix Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors at its exhibit booth during the American Academy of Orthopedic Surgeons (AAOS) meeting this week in San Francisco, CA.

8 Feb 2012

Exemestane has negative effect on postmenopausal women's bone health

Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.

8 Feb 2012